Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=10941d37-9403-442e-8751-4146081c39e3
Date 12/17/2016
Company Name Ocugen
Mailing Address 12635 E Montview Blvd. Aurora, CO 80045 USA
Company Description Ocugen is advancing two novel biologicals and a marketed drug product as a re-purposed drug under the U.S. Food and Drug Administration’s 505(b)(2) regulatory pathway to treat sight threatening ocular disorders.
Proceeds Purposes With this funding, we will continue our efforts to aggressively advance the OCU300 program toward an IND submission within a year, bringing this much needed therapy closer to the patients who need it.